VeriTeQ Corp. (fka VTEQ)

[Paulie Pennies]

Overall, with just $6 million of easily serviceable debt, shares are uniquely undervalued given this near-term catalyst of the FDA's Class I compliance deadline this October. Veriteq's technology was cleared by the FDA in 2004 and is covered by dozens of U.S. patents, providing a strong barrier to entry against would-be competitors. Veriteq has experience delivering shareholder value, selling a RFID device five years ago to Stanley Black & Decker for $47.9 million. Veriteq's CEO was additionally responsible for leading a former company to a NASDAQ uplisting and has 15 years executive experience with technology companies. Silverman personally owns 5,462,770 shares of Veriteq common stock, squarely aligning his interests with shareholders.